Home » Topics » BioWorld Science

BioWorld Science
RSS

Shanghai Ennova Biopharmaceutical describes new SSAO inhibitors

April 16, 2020

Betta Pharmaceuticals discloses new FGFR-4 inhibitors

April 16, 2020

Shenzhen Edk Pharmaceutical Technology patents androgen receptor antagonists

April 16, 2020

New Toll-like receptor 7 agonists discovered at Bristol-Myers Squibb

April 16, 2020

EM2D9 antibody shows potent antitumor activity in preclinical models of endometrial cancer

April 16, 2020

Novel hBCR/ABL1-induced zebrafish model of CML

April 16, 2020

TScan and Novartis collaborate to develop novel TCR-engineered T-cell therapies

April 16, 2020

Chinese regulatory approval granted to initiate phase II/III study of HBM-9161 in ITP

April 16, 2020

FDA authorizes phase II study of MultiStem cell therapy in trauma patients

April 16, 2020

Rac1 overexpression is involved in breast cancer chemoresistance by influencing DNA damage repair

April 16, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...